Drug intelligence / Profile preview

IR-2022-001

Development stage: Preclinical
Lead developer: Dong-A Pharmaceutical
Administration: Oral

Overview

IR-2022-001 is a functional ingredient currently in preclinical development by Dong-A Pharmaceutical for the improvement of hair health. The program is focused on safety assessment and the standardization of the ingredient for use in health functional foods (HFF). While the specific chemical composition and biological targets have not been disclosed, the ingredient is intended to address hair-related concerns such as hair loss or thinning. As a functional ingredient in the South Korean regulatory framework, it is positioned for the nutraceutical market rather than as a prescription pharmaceutical.

Beyond the preview

Go deeper on IR-2022-001.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on IR-2022-001.

Explore the full profile